LoE | GoR | SoR | % | |
---|---|---|---|---|
A. | na | na | 9.8±0.9 | 100 |
B. | na | na | 9.8±0.5 | 100 |
C. | na | na | 9.6±0.6 | 100 |
1. | 1a | A | 9.8±0.5 | 97 |
2. | 1a | A | 9.6±0.7 | 100 |
3. | 2b | B | 9.5±1.0 | 100 |
4. | 1a | A | 9.6±0.9 | 100 |
5. | 1a | A | 9.0±1.7 | 87 |
6. | 1a | A | 9.5±0.8 | 100 |
7. | 1a− | A | 8.9±1.2 | 73 |
8. | 5 | D | 8.9±1.3 | 100 |
9. | 1b | A | 9.2±1.2 | 90 |
10. | 1a | A | 9.4±0.8 | 97 |
11. | 1b* 5† | A* D† | 7.6±1.8 | 90 |
12. | 2b | B | 8.7±1.8 | 100 |
13. | 4 | C | 8.9±1.0 | 100 |
14 | 3b | C | 9.7±0.7 | 100 |
LoE and GoR are based on the recommendations of the Oxford Centre for Evidence-Based Medicine.
*The general statement is evidence based.
†The place in the treatment algorithm is based on expert consensus opinion.
na, not applicable.